Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Biotechnology > Genome-based Drug Discovery > European Cell Based Assays Markets
Category
Biotechnology (1524)
Antibody & Immunity (193)
Biomarker (169)
Biomaterials (56)
Biotechnology Equipment (348)
Gene Therapeutics & RNAi (104)
Genome-based Drug Discovery (204)
Molecular Targeted Therapeutics (51)
Personalized Medicine (57)
Regenerative Medicine (122)
Market Research Report

European Cell Based Assays Markets

Published by Frost & Sullivan
Published February, 2008 Product code 61911
Content info 82 Pages
Price
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


European Cell Based Assays Markets published by Frost & Sullivan in February, 2008. This report consists of 82 Pages and the price starts from US $ 6000.

Introduction

Abstract

This research service gives a detailed analysis of the cell based assay market in Europe from 2004-2014.

Table of Contents

1 EXECUTIVE SUMMARY

  • Overview
    • Executive Summary

2 GLOSSARY OF TERMS AND EXCHANGE RATES

  • Glossary of Terms and Exchange Rates
    • Glossary of Terms
    • Exchange Rates

3 INDUSTRY CHALLENGES

  • Identification of Challenges Facing the European Cell Based Assays Market
    • Industry Challenges

4 MARKET ENGINEERING RESEARCH FOR THE EUROPEAN CELL BASED ASSAYS MARKET

  • Forecasts for the European Cell Based Assays Market
    • The European Cell Based Assays Market
    • Research Methodology
    • Market Segmentation
    • Market Engineering Measurements
    • Market Drivers
    • Revenue Forecasts
    • Revenue Forecasts by Segments
    • Geographical Trends
    • Technology Trends
    • End-user Trends
    • Competitive Landscape
    • Competitive Landscape by Segments

5 MARKET ENGINEERING STRATEGIC RECOMMENDATIONS

  • Strategic Recommendations
    • Strategic Recommendations

6 DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Key Industry Participants
    • List of Key Industry Participants

7 DECISION SUPPORT DATABASES

  • Databases for Analysis
    • Pharmaceutical R&D Expenditure
    • R&D Expenditure as a Per cent of the Pharmaceutical Market
    • Number of Biotechnology Companies
    • Venture Capital Investments in Biotechnology R&D
    • Government Expenditure in R&D
Back to Top